| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Genome binding/occupancy profiling by high throughput sequencing
|
Matthew Weirauch
|
||||||
| GSE148396 |
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci
|
|
29 | Matthew Weirauch | Sep 23, 2021 | |||
| GSE167528 |
H3K27ac in SARS-CoV-2 infection
|
|
10 | Matthew Weirauch | Feb 26, 2021 | |||
| GSE176232 |
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci [ChIP-seq]
|
|
4 | Matthew Weirauch | Sep 23, 2021 | |||
| GSE176421 |
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci [ATAC-seq]
|
|
9 | Matthew Weirauch | Sep 23, 2021 | |||
| GSE183257 |
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis [ATAC-seq]
|
|
12 | Matthew Weirauch | Apr 26, 2022 | |||
| GSE184238 |
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis
|
|
48 | Matthew Weirauch | Apr 26, 2022 | |||
| GSE184301 |
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis [ChIP-seq]
|
|
12 | Matthew Weirauch | Apr 26, 2022 | |||
| GSE246059 |
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome (ATAC-Seq)
|
|
8 | Matthew Weirauch | Mar 12, 2024 | |||
| GSE246060 |
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome (ChIP-Seq)
|
|
26 | Matthew Weirauch | Mar 12, 2024 | |||
| GSE246062 |
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome
|
|
43 | Matthew Weirauch | Mar 12, 2024 |
